Synthetic milk compositions for optimal growth and development and prevention of obesity in male and female infant and children

US2016309768A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016309768-A1
Application numberUS-201415104027-A
CountryUS
Kind codeA1
Filing dateSep 1, 2014
Priority dateDec 12, 2013
Publication dateOct 27, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention concerns synthetic nutritional compositions for infants and young children up to the age of thirty-six months, particularly infant formulae and growing-up milks. The compositions vary according to gender and the age of the infant or young child. The compositions of the present invention have been designed to ensure balanced growth and to prevent obesity in infancy and later in life.

First claim

Opening claim text (preview).

1 . A synthetic nutritional composition for infants comprising: 60-85 kcal/100 ml energy; 3.9-6 g/100 ml lipid; and 600-810 mg/100 ml linoleic acid, wherein the composition is especially adapted to the nutritional needs of a male infant or child. 2 . The synthetic nutritional composition of claim 1 , wherein the composition also comprises: 710-930 mg/100 ml total polyunsaturated acids. 3 . The synthetic nutritional composition of claim 1 , wherein the composition also comprises a phospholipid selected from the group consisting of: 4.7-6.8 mg/100 ml of phosphatidylcholine; 6.3-10 mg/100 ml of phosphatidylethanolamine; and 1-2 mg/100 ml of phosphatidylinositol. 4 . The synthetic nutritional composition of claim 1 , wherein the composition also comprises: 21-30 mg/100 ml of phospholipids. 5 . The synthetic nutritional composition of claim 1 , wherein the composition comprises: 60-75 kcal/100 ml energy; 3.9-4.9 g/100 ml lipid; and 600-740 mg/100 ml linoleic acid; and further comprises a component selected from the group consisting of: 710-880 mg/100 ml total polyunsaturated acids, 5.4-6.8 mg/100 ml of phosphatidylcholine, 6.3-10 mg/100 ml of phosphatidylethanolamine, 1-1.3 mg/100 ml of phosphatidylinositol, and 21-26 mg/100 ml of phospholipids, and wherein the composition is especially adapted to a male infant of less than three months old. 6 . The synthetic nutritional composition of claim 1 , wherein the composition comprises: 70-85 kcal/100 ml energy; 5.0-6 g/100 ml lipid; and 660-810 mg/100 ml linoleic acid, and further comprises a component selected from the group consisting of: 755-930 mg/100 ml total polyunsaturated acids, 4.77-5.8 mg/100 ml of phosphatidylcholine, 6.3-10 mg/100 ml of phosphatidylethanolamine, 1.6-1.98 mg/100 ml of phosphatidylinositol, and 24-30 mg/100 ml of phospholipids, and wherein the composition is especially adapted to a male infant or young boy of more than three months old. 7 . A synthetic nutritional composition for infants comprising: 57-70 kcal/100 ml energy; 3.5-4.5 g/100 ml lipid; and 410-580 mg/100 ml linoleic acid, wherein the composition is especially adapted to the nutritional needs of a female infant or child. 8 . The synthetic nutritional composition of claim 5 , wherein the composition also comprises: polyunsaturated acids 510-680 mg/100 ml. 9 . The synthetic nutritional composition of claim 7 , wherein the composition also comprises a phospholipid selected from the group consisting of: 5.2-6.4 mg/100 ml of phosphatidylcholine; 5.8-8 mg/100 ml of phosphatidylethanolamine; and 0.9-1.7 mg/100 ml of phosphatidylinositol. 10 . The synthetic nutritional composition of claim 7 , wherein the composition also comprises: 19-25 mg/100 ml of phospholipids. 11 . The synthetic nutritional composition of claim 7 , wherein the composition comprises: 56-71 kcal/100 ml energy; 3.6-4.4 g/100 ml lipid; and 415-510 mg/100 ml linoleic acid, and further comprises a component selected from the group consisting of: 510-630 mg/100 ml total polyunsaturated acids; 5.2-6.4 mg/100 ml of phosphatidylcholine; 5.8-7.2 mg/100 ml of phosphatidylethanolamine; 0.9-1.1 mg/100 ml of phosphatidylinositol; and 20-24 mg/100 ml of phospholipids, and wherein the composition is especially adapted to a female infant of less than three months old. 12 . The synthetic nutritional composition of claim 7 , wherein the composition comprises: 56-71 kcal/100 ml energy; 3.6-4.3 g/100 ml lipid; and 475-580 mg/100 ml linoleic acid, and further comprises a component selected from the group consisting of: 550-670 mg/100 ml total polyunsaturated acids, 5.2-6.4 mg/100 ml of phosphatidylcholine, 6.4-7.9 mg/100 ml of phosphatidylethanolamine, 1.35-1.65 mg/100 ml of phosphatidylinositol, and 20-24 mg/100 ml of phospholipids, and wherein the composition is especially adapted to a female infant or young girl of more than three months old and less than 36 months old. 13 . A set of synthetic nutritional compositions for infants wherein: a first composition comprises 60-85 kcal/100 ml energy; 3.9-6 g/100 ml lipid; and 600-810 mg/100 ml linoleic acid; and a second composition comprises 57-70 kcal/100 ml energy; 3.5-4.5 g/100 ml lipid; and 410-580 mg/100 ml linoleic acid, the first composition is especially adapted to the nutritional needs of a male infant or child and the second composition is especially adapted to the nutritional needs of a female infant or child. 14 . The synthetic nutritional compositions according to claim 1 , wherein the composition is in a form selected from the group consisting of an infant formula in the form of a powder, liquid or concentrated liquid, or is a human milk fortifier. 15 . A method for ensuring balanced growth in male infants and young boys and preventing obesity in the male infants and young boys now and later in life comprising administering a synthetic composition comprising 60-85 kcal/100 ml energy; 3.9-6 g/100 ml lipid; and 600-810 mg/100 ml linoleic acid. 16 . A method for ensuring balanced growth in female infants and young girls and preventing obesity in the female infants and young girls now and later in life comprising administering a synthetic composition comprising 57-70 kcal/100 ml energy; 3.5-4.5 g/100 ml lipid; and 410-580 mg/100 ml linoleic acid. 17 . (canceled)

Assignees

Inventors

Classifications

  • Promoters of weight control and weight loss · CPC title

  • A23L33/40Primary

    Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence) · CPC title

  • Fatty acids or derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016309768A1 cover?
The invention concerns synthetic nutritional compositions for infants and young children up to the age of thirty-six months, particularly infant formulae and growing-up milks. The compositions vary according to gender and the age of the infant or young child. The compositions of the present invention have been designed to ensure balanced growth and to prevent obesity in infancy and later in life.
Who is the assignee on this patent?
Nestec Sa
What technology area does this patent fall under?
Primary CPC classification A23L33/40. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Oct 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).